從現有市場藥物之代謝物發展新型 NMDA 受體調節劑-(子計畫二)合成與設計新型 NMDA 受體調控劑治療精神分裂相關疾病 II
| dc.contributor.author | 孫仲銘 | zh_TW |
| dc.contributor.author | SUN CHUNG-MING | en_US |
| dc.contributor.department | 國立交通大學應用化學系（所） | zh_TW |
| dc.date.accessioned | 2016-03-29T00:01:14Z | |
| dc.date.available | 2016-03-29T00:01:14Z | |
| dc.date.issued | 2016 | en_US |
| dc.description.sponsorship | 科技部 | zh_TW |
| dc.identifier.govdoc | MOST105-2325-B009-001 | zh_TW |
| dc.identifier.uri | https://www.grb.gov.tw/search/planDetail?id=11722791&docId=479825 | en_US |
| dc.identifier.uri | https://ir.lib.nycu.edu.tw/handle/11536/130959 | |
| dc.language.iso | zh_TW | en_US |
| dc.title | 從現有市場藥物之代謝物發展新型 NMDA 受體調節劑-(子計畫二)合成與設計新型 NMDA 受體調控劑治療精神分裂相關疾病 II | zh_TW |
| dc.title | Discovery and synthesis of novel N-methyl D-asperate (NMDA) receptor modulator for their therapeutic utility in schizophrenia (II) | en_US |
| dc.type | Plan | en_US |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed to upon submission
- Description: